New Zealand markets closed

ImmunoPrecise Antibodies Ltd. (IPA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.19-0.17 (-2.67%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/04/2021
30/04/2020
30/04/2019
30/04/2018
Total revenue
18,735
17,912
14,058
10,926
5,441
Cost of revenue
7,101
6,374
6,024
5,632
2,990
Gross profit
11,634
11,538
8,034
5,295
2,451
Operating expenses
Research development
2,784
1,974
446.28
485.845
509.248
Selling general and administrative
15,439
13,608
8,981
9,119
6,446
Total operating expenses
19,092
15,714
12,081
11,520
7,212
Operating income or loss
-7,458
-4,176
-4,047
-6,225
-4,761
Interest expense
726
863
1,436
1,319
50.591
Total other income/expenses net
-771
-1,238
-82.316
-99.216
-323.182
Income before tax
-8,669
-5,995
-5,293
-7,613
-5,061
Income tax expense
1,352
1,345
-345.728
4.788
109.715
Income from continuing operations
-10,021
-7,340
-4,947
-7,617
-5,171
Net income
-10,021
-7,340
-4,947
-7,617
-5,171
Net income available to common shareholders
-10,021
-7,340
-4,947
-7,617
-5,171
Basic EPS
-
-0.45
-0.35
-0.60
-0.55
Diluted EPS
-
-0.45
-0.35
-0.60
-0.55
Basic average shares
-
16,474
13,629
12,542
9,107
Diluted average shares
-
16,474
13,629
12,542
9,107
EBITDA
-
-1,419
-448.577
-4,031
-4,553